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A breast cancer-associated mRNA originally cloned as a 475-bp partial cDNA from a library enriched for tumour cDNAs [Oncogene 16
(1998) 327] is expressed at high levels in breast and prostate cancer cells. Immunohistochemical analysis indicates that the protein is
expressed in primary breast tumours. We used RT-PCR to generate a full-length 2852 nt mRNA sequence that includes the hypothetical open
reading frame (ORF) for human RNF11. Our analysis shows that RNF11 encodes modular domains and motifs likely to interact with other
proteins involved in oncogenesis. Chief among these are the RING-H2 finger domain that could facilitate the degradation of specific
substrate(s) involved in oncogenesis and the PY motif which binds to WW-domain proteins, several of which are known to be E3 ubiquitin
ligases. Our GST-pulldown and immunoprecipitation results indicate that RNF11 interacts with the E3 ligase AIP4 when coexpressed with
RNF11 in mammalian cells.
D 2003 Elsevier B.V. All rights reserved.Keywords: WW-domain; PY motif; Breast cancer; RNF11; Protein:protein interaction1. Introduction
Malignancy at the molecular level is partly due to genetic
mutations and deletions that result in the alteration of
expression and function of various cellular genes. Progres-
sive and cumulative changes in cellular DNA result in
mutational activation of growth proliferative genes (e.g.,
proto-oncogenes) or inactivation of growth inhibitory genes
(e.g., tumour suppressor genes) [2–4]. In the development of
breast neoplasia, there are limited subsets of genes that will
be specifically expressed at various stages. Only a certain
number of these will be critical for the progression of
malignancy, especially those associated with the metastatic
spread of this disease. Once identified, such differentially0925-4439/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2003.07.001
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E-mail address: arun.seth@utoronto.ca (A. Seth).expressed genes will be useful for diagnosis and for moni-
toring disease progression, for facilitating the molecular
characterization of specific stages of tumour development
as well as assisting in patient prognosis and selection of
various treatment modalities. In addition, molecular defini-
tion of new genes involved in breast tumours will yield novel
targets for gene therapy and for therapeutic intervention.
The RNF11 gene was originally cloned as sequence
T2A10 from a library enriched for tumour cDNAs [1]. Its
full-length cDNA was extended ‘‘in silico’’ using overlap-
ping ESTs. We found it to be the human homologue of the
mouse RING-H2 protein RNF11. The mRNA for human
RNF11 is expressed at high levels in breast and prostate
cancer cells and the RNF11 gene encodes modular domains
and/or motifs known to interact with other proteins involved
in oncogenesis and signal transduction. The RING-H2
finger domain could facilitate protein:protein interactions
and the degradation of specific substrate(s) involved in the
cell cycle and the PY motif which binds to WW-domains
containing proteins, several of which are known to be
Fig. 1. (A) Diagram of RNF11 cDNA, ORF, and gene structure with the PY motif (PPPPY) and Ring-H2 domain indicated. (B) Complete mRNA sequence of human RNF11 as isolated by RT-PCR cloning.
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R. Kitching et al. / Biochimica et Biophysica Acta 1639 (2003) 104–112106HECT-type E3 ligases. Thus it is critical to identify the
substrates of the E3 ligases and characterization of those
substrates is crucial to understanding the potential role of
RNF11 in oncogenesis and development of targeted inhib-
itors/inducers of their activity.2. Methods
2.1. Culture of cell lines
Cancer cell lines were obtained from the American Type
Culture Collection (Manassas, VA) and cultured as recom-
mended. For transfections, HEK293T cells were maintained
in high glucose DME medium (Gibco) containing 10% FBS
without any antibiotics in 5% CO2 atmosphere.
2.2. RNA extraction, Northern blots, and hybridization
Total RNAwas extracted essentially according to Chomc-
zynski et al. [5]. Seven to ten micrograms of total RNA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Amino acid alignment of RNF11, RNF38, and KIAA1100. Top: aligned and
of relationships between PY motifs (circles) and RING-H2 domains (boxes).collected from cell lines as described above was size-frac-
tionated on a 1.2% agarose gel containing 2% formaldehyde
and transferred to a nylon membrane by the capillary transfer
method [6]. In addition, human multiple tissue Northern
blots (Clontech) were purchased. Northern blot hybridiza-
tions were done overnight at 42 jC with 2 106 cpm/ml of
32P-radiolabeled random primer synthesized probe using the
T2A10 cDNA as template (Amersham-Pharmacia Biotech.).
The blots were washed at 60 jC with three changes of wash
solution over 1 h and exposed to Kodak X-ray film after
drying. Blots were stripped as described [7], and rehybri-
dized with either GAPDH or 32P-radiolabeled h-actin cDNA
probe.
2.3. Preparation of antibodies
Antibodies were raised in rabbits against a synthetic
peptide sequence derived from the RNF11 C-terminal re-
gion and conjugated to keyhole limpet hemocyanin (KLH).
Rabbit IgG polyclonal antibodies were purified on a peptide
affinity column. 
 
 
 
 
 
 
 
 
 
 
shaded by the Clustal and Boxshade programs. Bottom: schematic diagram
Biophysica Acta 1639 (2003) 104–112 1072.4. Immunohistochemistry
The HistoStain SPKit (rabbit, Zymed, San Francisco, CA)
was used for immunohistochemical analysis of RNF11 pro-
tein in paraffin-embedded breast tissues. Immunoperoxidase
staining was as described [8] with the modification that
removal of endogenous peroxidase was followed by incuba-
tion in 0.1% trypsin (pH 7.4). RNF11 antibody (dil. 1:100, 40
Ag/ml) was added for 2 h at room temperature, negative
control sections were incubated with pre-immune serum. The
Elston and Ellis-modified [9] Bloom and Richardson method
was used for histological grading of breast tumours.
2.5. Vectors
The RNF11-mPY construct is derived from the RT-PCR
cloned coding region of RNF11 in PCMV-T2C-462 using
the Quikchange Site Directed Mutagenesis Kit, (Strata-
gene) to substitute an alanine for the encoded tyrosine at
position 40.
2.6. Transfection of 293-T cells
Asynchronously growing cells were plated in 100 mm
dishes and given a fresh complete medium change 2 h prior
to transfection. Two micrograms of tagged plasmid DNA
was mixed with 250 mM CaCl2 and 2 HBS (280 mM
NaCl, 50 mMHEPES, 1.5 mM sodium phosphate) (pH 7.05)
and incubated at room temperature for 15 min. The precip-
R. Kitching et al. / Biochimica etFig. 3. Amino acid alignment of RNF11 from various species. Aitate was then added to cells, which were incubated overnight
prior to medium change as described [10].
2.7. Expression of GST-fusion proteins and preparation of
GST-sepharose beads
BL21 bacteria transformed with expression vector con-
structs for GST-AIP4, GST-AIP4-WW1, or GST, were
grown in 50 ml culture medium until OD(600) = 0.5–1.
GST and GST fusion proteins were then induced by adding
IPTG to a final concentration of 0.5 mM in each culture
followed by incubation at 37 jC for 4 h. Bacteria were
pelleted by 20 min of centrifugation 5000 rpm at 4 jC.
Bacterial pellets were resuspended in 2 ml PBS (without Ca
or Mg) then lysed by three cycles of freeze–thaw, 3 min in
an EtOH-dry ice bath followed by 5 min at 37 jC, and
sonication on ice. After the addition of 0.22 ml 10% Triton
X-100 to the lysate, cell debris was removed by centrifu-
gation at 12,000 g for 5 min at 4 jC. Cleared lysates were
then incubated at 4 jC for 1 h with Glutathione-Sepharose
4B beads pre-washed in 3 1 ml PBS + 1% Triton X-100,
followed by two identical incubations with fresh wash
buffer. After washing, beads were resuspended in 50
Al PBS + 1% Triton X-100 to form a 50% slurry.
2.8. GST-pulldown from eukaryotic cell lysates
A 50% slurry of the GST-beads or GST-AIP4 beads was
incubated with 1 ml of transfected HEK293T, MCF7, orligned and shaded by the Clustal, and Boxshade programs.
Table 1
GenBank Accession numbers for EST and genomic clone DNA sequences
corresponding to the RNF11 gene in multiple species
Species cDNA Genomic
African clawed frog
(X. laevis)
CA78954
Western clawed frog
(S. tropicalis)
AL861696
Zebrafish (D. rerio) CA470012, BI476067,
AL913057
Pufferfish (F. rubripes) CAAB01000455.1
Fruitfly (D. melanogaster) AI513664, BG633419,
BI243482, NM_166753
AE003844
Nematode (C. elegans) Z35595 CAA84635.1
R. Kitching et al. / Biochimica et Biophysica Acta 1639 (2003) 104–112108HTB26 cell lysates extracted from 90% confluent T75
flasks for 3 h at 4 jC with constant end-over-end rotation.
The loaded beads were then washed with 1 ml NP40 lysis
buffer, mixed with 25 Al 3 SDS-PAGE sample buffer and
then boiled for 3 min.
2.9. Western blotting
Boiled samples were loaded onto 14% polyacrylamide gel
and after electrophoresis the proteins were transferred onto
Hybond-P membrane (Amersham). The resulting immuno-
blots were incubated overnight at 4 jC with antibodies in a
total volume of 1 ml. The secondary antibody used in the
immunoblot was a 1:5000 dilution of HRP-linked anti-rabbit
IgG. Peptide competition was done by incubation of anti-
bodies on ice in a total volume of 65 Al for 30 min with 3 Ag
of the RNF11 antibody and 30 Ag of the RNF11 peptide
immunogen used to induce the polyclonal serum.Fig. 4. (A) Expression of RNF11 in normal tissues and cancer cell lines. Multiple
with cDNA probes for RNF11. (B) Autoradiogram of Northern blotted total RNA3. Results
3.1. Structure and analysis of the RNF11 gene
In order to precisely define genes that are essential to the
initiation and development of the sporadic form of breast
cancer, we have isolated >1000 genes that may be activated or
inactivated during progression of breast cancer. This was
accomplished by subtractive hybridization and differential
display methods using matched breast tumour and normal
breast cell line RNAs [1,11,12]. Initial hybridization screen-
ing of 74 breast cancer-associated cDNAs arrayed on solid
membrane supports revealed them to be differentially
expressed between normal and malignant breast tissues using
complex cDNA probes. Among other genes, we discovered a
novel cDNA T2A10 which, after bioinformatic extension
with GenBank EST sequences, was found to encode a con-
sensus RING-H2 protein domain.We have also used RT-PCR
cloning to confirm and extend the T2A10 sequence. Addi-
tional searches with this sequence revealed that a similar
cDNA had been named RNF11. We have extended the exist-
ing RNF11 cDNA sequence (GenBank accessionAB024703)
by 330 nts at the 5V end and 482 nts at the 3V end of
AB024703 (RNF11) [13]. Our analysis discovered a poten-
tial WW-domain binding PPPPYmotif in the amino-terminal
region in addition to the carboxy terminal RING-H2 domain.
We have located the RNF11 gene on chromosome 1
between nts 1852121 and 1815179 of Human Genome
Project working segment NT_026948, where three exons
encode the entire 2852 nt RNF11 mRNA sequence (Fig. 1).
Interestingly, the splice junctions occur immediately after
the WW-binding motif and immediately before the RING-tissue Northern blots (MTN blot I and MTN blot II, Clonetech) hybridized
extracted from human prostate and breast tumour cell lines.
Fig. 5. RNF11 protein is expressed in MCF7 breast cancer cells.
Chemiluminescent visualization of proteins Western blotted after immuno-
precipitation from MCF7 cell extracts by anti-RNF11 antiserum or pre-
immune serum.
R. Kitching et al. / Biochimica et Biophysica Acta 1639 (2003) 104–112 109H2 domain and the exon between these regions contains two
sequences corresponding to the consensus Y–x–x–hydro-
phobic motif indicative of potential SH2 domain binding
sites (Fig. 1) [14]. One cDNA clone, AL537945, does
encode a sequence containing exon 1 joined to exon 3, that
is, exactly lacking exon 2, and represents the possibility of a
naturally occurring splice variant. At least 345 cDNAs can
be clustered to form the Unigene RNF11 cDNA cluster,
indicating that such a variant would be very rare. We also
found a likely pseudogene encoding a single open reading
frame (ORF) (GenBank XM_116772) that is contiguous and
identical to a sequence within chromosome eight.
In order to determine if the combination of a PY motif
with a carboxy terminal RING-H2 domain is unique, weFig. 6. RNF11 expression in primary breast cancer tissue. Shown is a primary br
antibody visualized by anti-rabbit-HRP second antibody and DAB substrate. The lo
arrows (left). A higher magnification of the cancer cell region is also shown (rigdownloaded FASTA formatted sequences for amino acid
sequences identified by the S.M.A.R.T database program as
containing RING domains. Four hypothetical amino acid
sequences representing two separate mRNAs for FLJ21343/
Ring finger protein 38 (RNF38) and KIAA1100 were found.
RNF38 and KIAA1100 appear to be closely related to each
other, and are encoded on separate regions of the human
genome (c9, RNF38; c5, KIAA1100). Although RNF11
possesses consensus amino acids indicative of a PY motif
and a RING-H2 domain, it does not otherwise share high
sequence identity with these proteins (Fig. 2).
3.2. Comparative genomics of RNF11
Our analysis of the extended RNF11 cDNA sequence has
discovered that homologues of the full-length protein are
encoded in the DNA of the zebrafish (Danio rerio), the
pufferfish (Fugu rubripes), the African clawed frog (Xen-
nopus laevis), and the Western clawed frog (Silurana tropi-
calis) as well as the fruitfly (Drosophila melanogaster) (Fig.
3). No TIGR or Unigene clusters encode the full-length of
RNF11 in frogs, fish, nematodes, or fruitflies. The ESTs we
have used to deduce them are presented in Table 1. The
zebrafish amino acid sequence is eight amino acids shorter
than other vertebrate RNF11 homologues, perhaps reflecting
the evolutionary divergence of the zebrafish and from other
vertebrates such as the pufferfish. Although unsupported by
pufferfish ESTs, we have included the in silico spliced and
translated protein sequences from ORFs encoded by ge-
nomic scaffold sequence CAAB01000455.1, and these
ORFs correspond exactly to the three exons of the human
RNF11 gene structure (Fig. 3 and Table 1).
We found that the nematode RNF11 RING-H2 domain
identified by Seki et al. [13] in GenBank entry Z35595
belongs to hypothetical protein CAA84635.1, derived from
Caenorhabditis elegans cosmid C01G6.4. This genomic
clone harbors five exons encoding a putative nematode
homologue of RNF11 rather than the three exons that encode
the vertebrate and fly genes. However, the final exon in botheast tumour section immunohistochemically stained brown by anti-RNF11
w magnification micrograph has cancer and normal cells marked by labeled
ht).
Fig. 7. RNF11 interacts with the E3 ligase AIP4. (A) Chemiluminescent
detection of anti-FLAG antibody on Western blot of proteins pulled down
by GST-AIP4 and GST proteins from extracts of HEK293T cells transfected
with FLAG-RNF11 or in whole cell extracts as indicated. (B) Chem-
iluminescent visualization of anti-FLAG Western blot using total cell
extracts from HEK293T cells transfected with Flag-tagged PY mutations of
RNF11 (mPY), Flag-tagged wild-type RNF11 (WT) after pull down with
GST-tagged AIP4 WW1 domain protein (GST-WW), GST only (GST), as
well as the whole cell extract alone (WCL). (C) Chemiluminescent
detection of endogenous RNF11 with anti-RNF11 antibody in the presence
and absence of the immunizing peptide on Western blots containing
proteins pulled down by GST-AIP4 WW1 domain protein from extracts of
the breast cancer cell line HTB26.
R. Kitching et al. / Biochimica et Bioph110the human and nematode genes begins with the first amino
acid of the RING-H2 domain. Other than 87% positive
identity with the human amino acid sequence in the RING-
H2 domain, there is no (default GenBank Blastp) significant
similarity in the remainder of the nematode sequence.
Although Seki et al. [13] did find a homologue of the
RNF11 RING-H2 domain, they have not published the
full-length homologue of RNF11 and the full-length se-
quence of nematode RNF11 remains elusive.
Both the fruitfly and the putative nematode amino acid
sequences lack the PPPPY sequence found in vertebrate
RNF11. The fruitfly gene structure is similar to that of
vertebrates in that it has three exons, however exon 3 of the
fruitfly includes all of the amino acid sequence corresponding
to exons two and three of the human gene. Although the 87%
sequence identity of the fruitfly RING domain with the
human is similar in value to that of the nematode sequence,
the fruitfly sequence is identical to human in the CIVP
sequence at the beginning of the RING-H2 domain and the
HIYH sequence between the two H residues diagnostic of the
RING-H2 domain. In addition, the fruitfly protein maintains
significant identity with the human protein outside the RING-
H2 domain (Fig. 3). It seems possible that the fruitfly
sequence is a true homologue of the vertebrate RNF11,
whereas the nematode gene is either highly divergent, not
yet properly sequenced, or represents an unrecognized related
gene family member.
3.3. Expression of RNF11 in human tumours and normal
tissue
Human RNF11 RNA appears to be expressed at low
levels in the lung, liver, kidney, pancreas, spleen, prostate,
thymus, ovary, small intestine, colon, and peripheral blood
lymphocytes, with stronger expression in the testes, heart,
brain and placenta (Fig. 4A). Highest expression of RNF11
is in the skeletal muscle. Three human prostate tumour cell
lines and three human breast tumour cell lines were exam-
ined for RNF11 expression (Fig. 4B). LnCAP prostate
tumour cells have the strongest expression of the RNF11
transcript, with lower levels of RNF11 mRNA in the PC3
prostate tumour line and the MDA-MB-468 breast tumour
cell line has the lowest expression of RNF11 mRNA (Fig.
4B). HTB126 (also known as Hs578T) breast tumour cells,
from which T2A10 was cloned, have the highest expression
of the RNF11 transcript (Fig. 4B).
3.4. RNF11 protein is expressed in breast tumour cell lines
RNF11 in the MCF7 breast cancer cell line was visualized
by chemiluminescent detection using anti-RNF11 antibodies
on an Western blot of proteins immunoprecipitated by anti-
RNF11 antisera from MCF7 cell extracts. A band corres-
ponding to RNF11 is seen only where anti-RNF11 antiserum
was used and not when pre-immune serum was used for
immunoprecipitation (Fig. 5).3.5. RNF11 protein is expressed in primary breast tumours
RNF11 protein expression in primary tumour and normal
breast tissues was monitored by immunohistochemistry
ysica Acta 1639 (2003) 104–112
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described in Methods. Our immunohistochemical results
reveal that RNF11 is predominantly expressed in the cyto-
plasm of breast cancer cells. Staining of primary breast
tissues revealed that anti-RNF11 antibody reacts with
corresponding protein in cancer cells, but not with surround-
ing stroma and weakly if at all in normal breast epithelial
cells (Fig. 6).
3.6. RNF11 interacts with the WW-domain E3 ligase AIP4
Interaction between human AIP4 and human RNF11 was
also tested by transfection of HEK-293T cells with FLAG-
RNF11 followed by GST-pulldown using recombinant GST-
AIP4 protein. Total cell extracts contained detectable
amounts of the recombinant FLAG-RNF11 as shown by
Western blotting with anti-FLAG antibody after the GST-
pulldown (Fig. 7A). The anti-FLAGWestern blot also shows
that FLAG-RNF11 protein interacts with GST-AIP4 and not
with GST.
Confirmation of the importance of the RNF11 PY
motif in this interaction is provided by a similar GST-
pulldown comparing mutant PY with wild-type Flag-
RNF11 protein. (Fig. 7B). The mutant RNF11-mPY has
an alanine in place of the tyrosine in the PY motif (Fig.
1), and this protein fails to show a band on the Flag
Western blot after GST-pulldown with the AIP4 WW1-
domain protein (Fig. 7B).
In general, PY motifs interact with WW-domains, and
this is consistent with our observation that recombinant
GST-AIP4-WW1 protein pulls down the endogenous
RNF11 protein from extracts of HTB26 cells (Fig. 7C).4. Discussion
The predicted amino acid sequence for the RNF11 cDNA
contains a RING-H2 domain and a WW-domain binding
motif, both of which mediate protein:protein interactions for
proteins involved in signal transduction pathways and
ubiquitin-mediated proteolysis (Fig. 1) [14,15]. We were
able to identify just two proteins that also contain both a PY
motif and a RING-H2 domain. These hypothetical proteins,
RNF38 and KIAA1100, are clearly related to each other
(Fig. 2, upper). The overall length of the proteins and the
amino acid sequence of the RING-H2 domains indicate that
they are not related to the RNF11 gene. The larger size of
RNF38 and KIAA1100 suggests that they may have addi-
tional functions in the amino-terminal region. Nevertheless,
RNF11, KIAA1100, and RNF38 may have similar functions
due to the positioning of the PY motifs relatively close to
the RING-H2 domain (Fig. 2, lower). These hypothetical
proteins have no published function, and although related to
each other, they are clearly not related to RNF11. This
leaves RNF11 as the only example yet of a RING-H2
domain protein that also possesses a functional PY motif.Many RING-H2 domains are known to interact with E2
proteins that provide the ubiquitin moiety to E3 ligases. It is
possible that RNF11 could mediate the association of one or
more such E2s with E3 ligases that contain WW-domains
such as, among others, the HECT-type ligases AIP4,
NEDD4 and Smurf1.
The PPPPY sequence of RNF11 is identical to that of
LMP2A, which has been shown to bind to WW-domain
polypeptides derived from AIP4, an E3 ubiquitin ligase that
mediates the ubiquitination and degradation of the breast
tumour suppressor Syk [16,17]. AIP4 is a HECT-type E3
ligase, a family of proteins that includes E6-AP, NEDD4,
Smurf1, and Smurf2 and others [18]. Each is characterized
by the HECT-domain, a 350-residue region located near the
carboxy terminus containing an essential cysteine capable of
forming thiol-ester intermediates with ubiquitin [19]. Al-
though E6AP lacks a WW-domain, they exist in many other
HECT domain proteins such as NEDD4, AIP4, Smurf 1 and
Smurf2. Within the WW-domain, conserved tryptophans
form a hydrophobic pocket capable of binding the proline-
rich sequences known as WW-binding or PY motifs [20,21].
We found that GST-AIP4 binds RNF11 as shown by
GST-pulldown of endogenous RNF11 from breast tumour
cell lines, and of FLAG-tagged RNF11 from transfected
HEK293T cells (Figs. 7A,C) [22]. This interaction is de-
pendant upon the wild-type PY motif of RNF11, which
interacts with WW-domain 1 of AIP4 (Fig. 7B). It appears
that WW-domain 1 of AIP4 is sufficient for interaction with
endogenous RNF11 in HTB26 cells (Fig. 7C).
Interactions of the RNF11 RING-H2 domain have not
yet been tested. However, as with the PPPPY motif, it is
highly conserved in all vertebrate genomes examined here.
Unlike the WW-binding motif, much of the RING-H2
domain appears to be conserved in both the nematode and
the fruitfly. The failure to find a highly conserved worm or
insect ORF for RNF11 may simply be a product of incom-
plete genome and cDNA databases. On the other hand, the
sudden evolutionary gain of a PPPPY motif and the high
overall identity in all the vertebrates leads one to speculate
that RNF11 has a function unique to the life of vertebrates.
One possibility lies in the fact that the WW-domain con-
taining HECT-type E3 ligase Smurf2 is an essential regula-
tor of the TGFh receptor complex through its interactions
with Smad proteins, however, no TGFh-like fly genes have
yet been described. Although homologues of the Smad
family proteins exist in the nematode and fruitfly, they act
within BMP-like and activin-like receptors. It is expected
that continued efforts to fully characterize all genes in most
genomes will answer this question.Acknowledgements
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